AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common conditions, today announced that Todd Bazemore has been appointed President and Chief Executive Officer as well as a member of the company’s Board of Directors. Mr. Bazemore is an accomplished biopharma executive with extensive leadership experience in clinical- and commercial-stage drug development.
